The International Centre for Genetic Engineering and Biotechnology (ICGEB) is in collaboration with drug major Sun Pharma to use the recombinant EDIII-based sub-unit dengue vaccine candidate to develop an injectible vaccine that protects against all four dengue strains are endemic to India. ICGEB has also developed the first 1 day Dengue Diagnostic Test and more than 5 million tests were sold in 2016.
Quick Information
View All
Acces sibility Controls